Shuman Rb,Schuster Dp,Zuckerman Gr..“Prophylactic therapy for stress ulcer bleeding: a reappraisal,”.Ann Intern Med. 1987;106 (4): 562-7
2.
Peura Da,Johnson Lf..“Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients in an intensive care unit,”.Ann Intern Med. 1985;103:173-7
Cook Dj,Fuller Hd,Guyatt Gh.“Risk factors for gastrointestinal bleeding in critically ill patients,”.NEJM. 1994;330 (6): 377-81
5.
Ben-Menachem T,Fogel R,Patel Rv.“Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit: a randomized, controlled, single-blind study,”.Ann Intern Med. 1994;121 (8): 568-75
6.
Fagon Jy,Chastre J,Hance Aj.“Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay,”.Am J Med. 1993;94:281-8
7.
Langer M,Cigada M,Mandelli M,Mosconi P,Tognomi G..“Early-onset pneumonia: a multicenter study in intensive care units,”.Intensive Care Med. 1987;13:342-6
8.
Lowy Fd,Carlisle Ps,Adams A,Feiner C..“The incidence of nosocomial pneumonia following urgent endotracheal intubation,”.Infect Control. 1987;8:245-8
9.
Zinner Mj,Turtinen L,Gurll Nj..“The role of acid and ischemia in production of stress ulcers during canine hemorrhagic shock,”.Surgery. 1975;77:807
10.
Arvidsson S,Haglund V..“Acute gastric ulceration in septic shock: an experimental model,”.Scand J. Gastroenterol. 1984;105:46
11.
Goodman Aa,Osborne Mp..“An experimental model and clinical definition of stress ulceration,”.Surg Gynecol Obstet. 1972;134 (4): 563
12.
Levine Ba..“Pathophysiology and mechanisms of stress ulcer injury,”.Pharmacotherapy. 1987;7 (Suppl 6 Pt 2): 90s-4s
13.
Lucas Ce,Sugawa C,Riddle J.“Natural history and surgical dilemma of stress gastric bleeding,”.Arch Surg. 1971;102:266-73
14.
Tryba M..“Stress bleeding prophylaxis with sucralfate: pathophysiologic basis and clinical use,”.Scand J Gastroenterol. 1990;25 (Suppl 173): 22
15.
Stannard Va,Hutchinson A,Morris Dl,Byrne A..“Gastric exocrine ‘failure’ in critically ill patients. Incidence and associated features,”.Br Med J. 1988;296:155-6
16.
Miller Ta..“Mechanisms of stress-related mucosal damage,”.Am J Med. 1987;83 (Suppl 6A): 8-14
17.
Parks Da,Bulkley Db,Granger Dn..“Role of oxygen-derived free radicals in digestive tract diseases,”.Surgery. 1983;94:415-22
18.
Itoh M,Guth Ph..“Role of oxygenderived free radicals in hemorrhagic shockinduced gastric lesions in the cat stomach,”.Gastroenterology. 1986;90:362
19.
Duckworth C,Peura Da..“H. pylori infection and GI disease: what critical care physicians need to know,”.J Crit Ill. 1995;10:105-17
Fiorucci S,Clausi Gc,Farinelli M.“Intragastric pH monitoring during antisecretory therapy in patients with gastrointestinal bleeding,”.Am J Gastroenterol. 1989;84 (11): 1416-20
27.
Ballesteros Ma,Hogdon Dl,Koss Ma,Isenberg Ji..“Bolus or intravenous infusion of ranitidine. Effects on gastric pH and acid secretion: a comparison of relative cost and efficacy,”.Ann Intern Med. 1990;112:334-9
28.
Szabo S,Hollander D..“Pathway of gastrointestinal protection and repair: mechanisms of sucralfate,”.Am J Med. 1989;86 (Suppl 6A): 23-31
29.
Frydman Gm,Penney Ag,Malcontenti C.“Inability of cytoprotection to occur during a period of gastric ischemia,”.Dig Dis Sci. 1991;36 (10): 1353-60
30.
Laudanno Om,Bedini Oa,Cesolari Ja.“Sucralphate in the prevention of acute gastric lesions induced by ischemia-reperfusion,”.Ital J Gastroenterol. 1992;24 (7): 380-2
31.
Tryba M,Kurz-Muller K,Donner B..“Plasma aluminum concentrations in long term mechanically ventilated patients receiving stress ulcer prophylaxis with sucralfate,”.Crit Care Med. 1994;22 (11): 1769-74
32.
Sachs G..“Proton pump inhibitors and acid-related diseases,”.Pharmacotherapy. 1997;17 (1): 22-37
33.
Garnett Wr..“Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease,”.Am J. Hosp Pharm. 1993;50 (Suppl 1): 11-18
34.
Phillips Jo,Metzler Mh,Palmieri Mtl.“A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage,”.Crit Care Med. 1996;24 (11): 1793-800
35.
Sharma Vk,Vasudeva R,Howden Cw.“Simplified lansoprazole suspension (SLS): a proton pump inhibitor (PPI) in a liquid formulation that works,”.Am J Gastroenterol. 1998;93:A1647
Wilder-Smith Ch,Halter F,Ernst T.“Loss of acid suppression during dosing with H2-receptor antagonists,”.Aliment Pharmacol Ther. 1990;4 (Suppl 1): 15-27
38.
Smith Jtl,Gavey C,Nwokolo Cu,Pounder Re..“Tolerance during 8 days of high-dose H2-blockade,”.Aliment Pharmacol Ther. 4 (Suppl 1): 47-63
39.
Nwokolo Cu,Smith Jtl,Gavey C.“Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine,”.Aliment Pharmacol Ther. 1990;4 (Suppl 1): 29-45
40.
Merki Hs,Wilder-Smith Ch..“Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?”.Gastroenterol. 1994;106:60-4
41.
Levy Mj,Dipalma Ja..“Stress ulcer prophylaxis may not be for everyone,”.Curr Opin Crit Care. 1996;2:129-33
42.
Chung-Ja MC,Randall Ht..“Osmolality of liquid and defined formula diets: the effects of hydrolysis by pancreatic enzymes,”.JPEN. 1981;5:7-10
43.
Pingleton Sk,Hadizma S..“Enteral alimentation and gastrointestinal bleeding in mechanically ventilated patients,”.Crit Care Med. 1983;11:13-6
44.
Skillman Jj,Libson A,Long Pc.“15(R)-15-methyl prostaglandin E2 does not prevent gastrointestinal bleeding in seriously ill patients,”.Am J Surg. 1984;147:451-5
45.
Van Essen Ha,Van Blankenstein M,Wilson Jh.“Intragastric prostaglandin E2 and the prevention of gastrointestinal hemorrhage in ICU patients,”.Crit Care Med. 1985;13:957-60
46.
Zinner Mj,Rypins Eb,Martin Lr.“Misoprostol versus antacid titration for preventing stress ulcers in postoperative surgical ICU patients,”.Ann Surg. 1989;210 (5): 590-5
47.
Martin Lf,Booth Fv,Reines Hd.“Stress ulcer and organ failure in intubated patients in surgical intensive care units,”.Ann Surg. 1992;215:332-7
48.
Szabo S,Trier Js,Frankel Pw..“Sulfhydryl compounds may mediate gastric cytoprotection,”.Science. 1981;214:200-2
49.
Parmar Ns,Tariq M,Ageel Am..“Gastric anti-ulcer and cytoprotective effect of selenium in rats,”.Toxicol Appl Pharmacol. 1988;91:122-30
50.
Al-Moutairy Ar,Tariq M..“Effect of vitamin E and selenium on hypothermic restraint stress and chemically-induced ulcers,”.Dig Dis Sci. 1996;41 (6): 1165-71
51.
Ekman T,Bagge U,Risberg B,Soussi B..“Ascorbate preserves gastric mucosal metabolism and microcirculation after hemorrhagic shock and retransfusion in rats,”.Eur Surg Res. 1995;27:39-48
52.
Granger Dn,Harnandez La,Grisham Mb..“Reactive oxygen metabolites: mediators of cell injury in the digestive system,”.Viewpoints Dig Dis. 1986;18:13-16
53.
Knodell Rg,Rosenthal Le..“Stress-related mucosal damage: critical evaluation of potential new therapeutic agents,”.Pharmacotherapy. 1987;7:104s-109s
54.
Stuart Rc,Gorey Tf,Kay E.“Acute gastric stress ulceration: prophylaxis with allopurinol,”.J R Coll Surg Edinb. 1989;34:321-5
55.
Salim As..“Protection against stress-induced gastric mucosal injury by free radical scavengers,”.Intensive Care Med. 1991;17:455-60
56.
Itoh M,Guth Ph..“Role of oxygenderived free radicals in hemorrhagic shockinduced gastric lesions in rats,”.Gastroenterology. 1985;88:1162-7
Cook D,Guyatt G,Marshall J.“A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation,”.NEJM. 1998;338 (12): 791-7
59.
Driks Mr,Craven De,Celli Br.“Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers: the role of gastric colonization,”.NEJM. 1987;317:1376-82
60.
Tryba M..“Risk of acute stress bleeding and nosocomial pneumonia in ventilated intensive care unit patients: sucralfate versus antacids,”.Am J Med. 1987;83:117
61.
Gross Pa,Neu Hc,Aswapokee P.“Deaths from nosocomial infection: experience in a university hospital and a community hospital,”.Am J Med. 1980;68:219-23
62.
Craven De,Kunches Lm,Kilinsky V.“Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation,”.Am Rev Resp Dis. 1986;133:792-6
63.
Reed Pj,Smith Pl,Hainkes K,House Fr,Walters Cl..“Gastric juice N-nitrosamines in health and gastrointestinal disease,”.Lancet. 1980;2:550
64.
Du Moulin Gc,Paterson Dg,Hedley-White J,Libson A..“Aspiration of gastric bacteria in antacid treated patients: a frequent cause of postoperative colonisation of the airway,”.Lancet. 1982;1:242-5
65.
Donowitz Lg,Page MC,Mileur Bl,Guenthner Sh..“Alteration of normal gastric flora in critical care patients receiving antacid or cimetidine therapy,”.Infect Control. 1986;7:23-6
66.
Daschner F,Kappstein I,Engels I.“Stress ulcer prophylaxis and ventilation pneumonia: protection by antibacterial cytoprotective agents?”.Infect Control Hosp Epidemiol. 1988;9:59-65
67.
Ruddell Ws,Axon At,Findlay Jm.“Effect of cimetidine on the gastric bacterial flora,”.Lancet. 1980;1:672-4
68.
Stockbrugger Rw,Cotton Pb,Eugenides N.“Intragastric nitrates, nitrosamines and bacterial overgrowth during cimetidine treatment,”.Gut. 1982;23:1048-54
69.
Lehot Jj,Deleat-Besson R,Bastien O.“Should we inhibit gastric acid secretion before cardiac surgery,”.Anesth Analg. 1990;70:185-90
70.
Hillman Km,Riordan T,O'Farrel Sm.“Colonization of the gastric contents in critically ill patients,”.Crit Care Med. 1982;10:444-7
71.
Cameron Jl,Reynolds J,Zuidema Gd..“Aspiration in patients with tracheostomies,”.Surg Gynecol Obstet. 1973;136:68-70
72.
Craven De,Daschner Fd..“Nosocomial pneumonia in the intubated patient: role of gastric colonization,”.Eur J Clin Microbiol Infect Dis. 1989;8:40-50
73.
Deitch Ea,Wintertin J,Li M,Berg R..“The gut as a portal of entry for bacteremia—role of protein malnutrition,”.Ann Surg. 1987;205:681-92
74.
Gray Jda,Shiner M..“Influence of gastric pH on gastric and jejunal flora,”.Gut. 1977;8:574-81
75.
Gianotti L,Alexander Jw,Fukushima R,Pyles T..“Reduction of bacterial translocation with oral fibroblast growth factor and sucralfate,”.Am J. Surg. 1993;165:195-201
76.
Jacobs S,Chang Rws,Lee B,Bartlett F..“Continuous enteral feeding: a major cause of pneumonia among ventilated intensive care unit patients,”.J Par Ent Nutr. 1990;14:353-6
77.
Feistauer Sm,Laggner Am,Makristathis A,Georgopoulos A..“Influence of stress ulcer prophylaxis on translocation of bacteria from the intestinal tract in rats” [Abstract].Circ Shock. 1991;34:25
78.
Tryba M,Cook Dj..“Gastric alkalin-ization, pneumonia, and systemic infections: the controversy,”.Scand J Gastroenterol. 1995;30 (Suppl): 210:53-9
79.
Meijer K,Van Saene Hfk,Hill Jc..“Infection control in patients undergoing mechanical ventilation: traditional approach versus a new development—selective decontamination of the digestive tract,”.Heart Lung. 1990;19:11-20
80.
Gomez Ec,Markowsky Sj,Rotschafner Jc..“Selective decontamination of the digestive tract in intensive care patients: review and commentary,”.Ann Pharmacother. 1992;26:963-76
81.
Ortiz Je,Sottile Fd,Sigel P.“Gastric colonization as a consequence of stress ulcer prophylaxis: a prospective, randomized trial,”.Pharmacotherapy. 1998;18 (3): 486-91
82.
Tryba M..“The gastropulmonary route of infection—fact or fiction?”.Am J Med. 1991;91 (Suppl 2A): 135s-146s
83.
Trofe J,Peterson Am..“The role of H2-receptor antagonists in the pathogenesis of nosocomial pneumonia in mechanically ventilated patients,”.Pharmacotherapy. 1998;18 (4): 808-15
84.
Prod'Hom G,Leuenberger P,Koerfer J.“Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer,”.Ann Intern Med. 1994;120:653-62
85.
Eddleston Jm,Vohra A,Scott P.“A comparison of the frequency of stress ulceration and secondary pneumonia in sucralfate- or ranitidine-treated intensive care unit patients,”.Crit Care Med. 1991;19:1491-6
86.
Winter R,Macgowan Ap,Speller Dc.“Gastric pH and colonisation in sucralfate treated patients” [Letter],.Intensive Care Med. 1989;15:216-7
87.
Stannard Va,Hutchinson A,Morris Dl,Byrne A..“Gastric exocrine failure in critically ill patients: incidence and associated features,”.Br Med J (Clin Res Ed). 1988;296:155-6
88.
Tryba M,Mantey-Stiers F..“The antibacterial activity of sucralfate in human gastric juice,”.Am J Med. 1987;83:125-7
Eddleston Jm,Pearson Rc,Holland J.“Prospective endoscopic study of stress erosions and ulcers in critically ill adult patients treated with either sucralfate or placebo,”.Crit Care Med. 1994;22:1949-54
92.
Cook Dj,Walter Sd,Cook Rj.“Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients,”.Ann Intern Med. 1998;129:433-40
93.
Reusser P,Zimmerli W,Scheidegger D.“Prospective endoscopic study of stress erosions and ulcers in critically ill neurosurgi-cal patients: current incidence and effect of acid-reducing prophylaxis,”.Crit Care Med. 1990;18:270-4
94.
Schuster Dp,Rowley H,Feinstein S.“Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit,”.Am J Med. 1984;76:623-30
95.
Ben-Menachem T,McCarthy Bd,Fogel R.“Prophylaxis for stress-related gastrointestinal hemorrhage: A cost effectiveness analysis,”.Crit Care Med. 1996;24 (2): 338-45
96.
Richter J,Huse D,Thompson D.“Sucralfate suspension versus acid neutralization as stress-ulcer prophylaxis during mechanical ventilation: economic implications for critical care medicine,”.Am J Gastroenterol. 1989;84:1168
